1-SUBSTITUTED-3-(NAPHTHALEN-1-YLSULFONYL)-5-(PIPERAZIN-1-YL)-1H-INDAZOLE COMPOUNDS AS 5-HYDROXYTRYPTAMINE-6 LIGANDS
申请人:Liu Kevin Guangcheng
公开号:US20090318470A1
公开(公告)日:2009-12-24
The disclosure is directed to compounds of Formula I:
processes for their preparation, treatment of central nervous system (CNS) disorders and methods for the modulation of 5HT
6
activity.
该披露涉及到Formula I的化合物:它们的制备过程,治疗中枢神经系统(CNS)疾病以及调节5HT6活性的方法。